Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 43, 2014 - Issue 2
Submit an article Journal homepage
418
Views
34
CrossRef citations to date
0
Altmetric
Articles

Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still’s disease

K-H JungDivision of Rheumatology, Centre for Rheumatism, Inha University Hospital, Incheon, Republic of Korea
,
J-J KimDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea
,
J-S LeeDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea
,
W ParkDivision of Rheumatology, Centre for Rheumatism, Inha University Hospital, Incheon, Republic of Korea
,
T-H KimDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea
,
J-B JunDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea
&
DH YooDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of KoreaCorrespondence[email protected]
 show all
Pages 162-169 | Accepted 08 Jul 2013, Published online: 18 Oct 2013

References

  • Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still’s disease. Ann Rheum Dis 2006;65:564–72.
  • Fautrel B. Adult-onset Still disease. Best Pract Res Clin Rheumatol 2008;22:773–92.
  • Chen DY, Lan JL, Lin FJ, Hsieh TY. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still’s disease. J Rheumatol 2004;31:2189–98.
  • Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol 2003;73:213–24.
  • Boraschi D, Dinarello CA. IL-18 in autoimmunity: review. Eur Cytokine Netw 2006;17:224–52.
  • Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still’s disease. Arthritis Rheum 2001;44:550–60.
  • Kawaguchi Y, Terajima H, Harigai M, Hara M, KamataniN. Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still’s disease. Arthritis Rheum 2001;44:1716–17.
  • Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, RubinsteinM. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999;10:127–36.
  • Hurgin V, Novick D, Rubinstein M. The promoter of IL-18 binding protein: activation by an IFN-gamma-induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta. Proc Natl Acad Sci USA 2002;99:16957–62.
  • Novick D, Schwartsburd B, Pinkus R, Suissa D, Belzer I, Sthoeger Z, A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine 2001;14:334–42.
  • Mazodier K, Marin V, Novick D, Farnarier C, Robitail S, Schleinitz N, Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 2005;106:3483–9.
  • Novick D, Elbirt D, Miller G, Dinarello CA, Rubinstein M, Sthoeger ZM. High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein. J Autoimmun 2010;34:121–6.
  • Ianello A, Boulassel MR, Samarani S, Tremblay C, Toma E, Routy JP, HIV-1 causes an imbalance in the production of interleukin-18 and its natural antagonist in HIV-infected individuals: implications for enhanced viral replication. J Infect Dis 2010;201:608–17.
  • Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, Preliminary criteria for classification of adult Still’s disease. J Rheumatol 1992;19:424–30.
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
  • van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361–8.
  • Pouchot J, Sampalis JS, Beaudet F, Carette S, Décary F, Salusinsky-Sternbach M Adult Still’s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 1991;70:118–36.
  • Kim SH, Eisenstein M, Reznikov L, Fantuzzi G, Novick D, Rubinstein M, Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA 2000;97:1190–5.
  • Shimizu C, Fujita T, Fuke Y, Ito K, Satomura A, Matsumoto K, High circulating levels of interleukin-18 binding protein indicate the severity of glomerular involvement in systemic lupus erythematosus. Mod Rheumatol 2012;22:73–9.
  • Fautrel B, Le Moel G, Saint-Marcoux B, Taupin P, Vignes S, Rozenberg S, Diagnostic value of ferritin and glycosylated ferritin in adult onset Still’s disease. J Rheumatol 2000;28:322–9.
  • Shimizu M, Nakagishi Y, Kasai K, Yamasaki Y, Miyoshi M, Takei S, Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6. Cytokine 2012;58:287–94.
  • Yoshida Y, Sakamoto M, Yokota K, Sato K, Mimura T. Tocilizumab improved both clinical and laboratory manifestations except for interleukin-18 in a case of multiple drug-resistant adult-onset Still’s disease. Intern Med 2011;50:1757–60.
  • Nagashima T, Iwamoto M, Matsumoto K, MinotaS. Interleukin-18 in adult-onset Still’s disease: treatment target or disease activity indicator? Intern Med 2012;51:449.
  • Jung SY, Park YB, Ha YJ, Lee KH, Lee SK. Serum calprotectin as a marker for disease activity and severity in adult-onset Still’s disease. J Rheumatol 2010;37:1029–34.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.